What we do
Conventional solvent extraction is economically brittle and fundamentally unsuited to the distributed, dilute, heterogeneous character of legacy critical mineral feedstocks. Our team of innovators is deploying AI-integrated platforms that co-optimize biological liberation and programmable molecular separation in a single closed-loop system. Cinderae Nova is paving the way for accessing critical minerals tied up in legacy assets, stranded feedstocks, and dilute wastestreams.
Our Platform
The real obstacle to domestic Critical Mineral independence is not the existence of resources - it is the absence of economically viable separation technology for heterogeneous domestic feedstocks.
Modular deployability
Scaling ligand separation architecture to address legacy feedstocks widely distributed across the USA necessitates a decentralized business model that is built on modularity and easy of deployment.
SynBio production & manufacture
The conclusions from Cinderae Nova's Techno Economic Analysis (TEA) are succinct - economic viability of our business model requires that our ligand architecture is manufactured at scale using Synthetic Biology (SynBio) and precision fermentation as opposed to Solid-phase peptide synthesis (SPPS) giving us an even deeper IP moat for investor confidence.
Scalable architecture
Field deployed process engineering requires robustness and reliability because real-world feed streams do not behave predictably. Fouling mitigation, surface chemistry regeneration, process cycle optimization, and repeatable efficacy require a reliable, proven technology platform.
Programmable Molecular Selectivity
Cinderae Nova's AI ligand design pipeline is focused on capturing critical elements from leachate, achieving intra-series discrimination impossible with solvent extraction.
"The world needs to act urgently to develop diverse and sustainable sources of critical minerals — or risk trading one dependency for another."
Fatih Birol, Executive Director, IEA